Papers on "Johnson & Johnson's Marketing Mix" and similar term paper topics
Paper #096922 ::
Johnson & Johnson's Marketing Mix
Buy and instantly download this paper now
A review of Johnson & Johnson (JNJ), a recognized global leader and manufacturer of health care products.
Written in 2006; 3,003 words; 5 sources; MLA;
$ 88.95
Paper Summary:
This paper reviews and discusses the global leader in health care products, Johnson & Johnson (JNJ). According to the paper, JNJ has over 200 subsidiaries with offices in nearly every nation of the world. The paper reports that Johnson & Johnson has gone through a variety of structural and organizational structures in the last twenty years and today is centered on a market segment-based approach which comprises their consumer, medical devices & diagnostics and pharmaceuticals businesses.
Outline:
Company Description
Business Segments are aligned to Target Markets
Pharmaceutical Segment
Medical Devices & Diagnostics
Consumer
Product Strategy
Pricing Strategies
Distribution Strategy
Promotions and Marketing Communications
Conclusion
From the Paper:
"JNJ's move into markets that require more sophistication in drug development and production is also exemplified by their move into the market for medications to treat Schizophrenia, an area of their business that made up 18% of total 2006 pharmaceutical revenues. The anemia market is another source of challenge for the company as price erosion has been necessary to stem market share losses. We assume revenue erosion in the mid-single digits over the next 3 years with continued competition from Amgen and some modest negative effects from Roche's Cera, expected to launch in May 2007. The anemia franchise (Procrit/Eprex) made up 14% of JNJ's pharmaceutical sales in 2006.
The MD&D division has enjoyed industry leadership, particularly at the company's Cordis business. This previously fast-growing business made up 20% of JNJ's MD&D sales in 2006 and a significant proportion of its profit. Noteworthy competition from Boston Scientific, Abbott, and Medtronic is likely to erode market share beginning in 2007, driving Cordis sales declines in the range of 4% to 19% in 2007-10. The Conor acquisition is expected to be successful.The Consumer division should benefit from the recent acquisition of Pfizer's consumer line."
Keywords:
pharmaceutical consumer segment sales pricing methodologies market share distribution channels
More papers on "Johnson & Johnson's Marketing Mix"
-
Paper #067541 :: Johnson & Johnson (
1,660 words; 13 sources; MLA )
-
Paper #062743 :: Johnson & Johnson, Inc. (
3,960 words; 10 sources; MLA )
-
Paper #093372 :: Johnson & Johnson: Social Responsibility (
6,050 words; 15 sources; MLA )
-
Paper #008948 :: 'Johnson & Johnson' as a Rational Organization (
980 words; 3 sources; MLA )
-
Paper #061254 :: Johnson and Johnson (
1,564 words; 6 sources; MLA )
About AcaDemon
We have thousands of high-quality term papers, research papers, essays, book reports and dissertations on every topic. At AcaDemon, you can download those term papers to help you write yours! You can be sure that the term paper, essay, book report or research paper, you download are top-quality, competitively priced and high-level work.
 Look for more research papers, essays and book reports on
Johnson & Johnson's Marketing Mix
|
If you can't find your topic here, try another search
or try our affordable, unique custom paper alternative
Custom Research Services include:
- Papers written from scratch, according to your specifications.
Every paper is UNIQUE - Guaranteed
- Professional, top-notch writers
- All topics covered
- Any deadline
- Your satisfaction guaranteed
Place a Custom Research order now
Find out more about Custom Research
|
|
|
